LabCompass

Publications

152

Citations

1,350

Est. group size

Recurring co-author estimate

Active years

45

Publishing since 1982

Research summary
AI-generated

Marc A. Rodwin studies the policies, laws, and economics that govern pharmaceutical pricing and the healthcare system, with a strong focus on how drug prices are set and controlled. Much of the work compares the United States with European countries (the UK, France, and Germany) and examines issues like Medicare drug price negotiation, conflicts of interest among clinicians, and corruption in the pharmaceutical industry. The research sits at the intersection of health policy, law, and drug economics rather than laboratory pharmacology.

Pharmaceutical pricing policyDrug cost control (US and Europe)Conflicts of interest in medicineHealth law and regulationPharmaceutical industry ethics

Publication activity has been uneven over the past decade, with peak output around 2019 and 2021 and a lower, steadier rate of about two papers per year more recently.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.2/year recently
2017: 1 publication172018: 3 publications182019: 9 publications192020: 3 publications202021: 10 publications10212022: 2 publications222023: 1 publication232024: 4 publications242025: 3 publications252026: 1 publication26
Recent publications
Publishes in
  • International Journal of Health Services×4
  • SSRN Electronic Journal×4
  • Elsevier eBooks×3
  • BMJ×2
  • European Journal of Cancer×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile